SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9649951
Source:
http://linkedlifedata.com/resource/pubmed/id/9649951
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011860
,
umls-concept:C0021641
,
umls-concept:C0038766
,
umls-concept:C0087111
,
umls-concept:C0205195
pubmed:issue
3
pubmed:dateCreated
1998-9-8
pubmed:abstractText
To determine the effect(s) on glucose control, insulin dose, and circulating insulin levels of the addition of a sulfonylurea (glipizide) to the treatment regimen of patients with insulin-requiring type 2 diabetes mellitus.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/MO1-RR-30
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8508335
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Glipizide
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0168-8227
pubmed:author
pubmed-author:BurseyD LDL
,
pubmed-author:DeAtkineD DDD
,
pubmed-author:EnglishJ SJS
,
pubmed-author:FeinglosM NMN
,
pubmed-author:LobaughBB
,
pubmed-author:McNeillD BDB
,
pubmed-author:ThackerC RCR
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
193-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9649951-Adult
,
pubmed-meshheading:9649951-Aged
,
pubmed-meshheading:9649951-Blood Glucose
,
pubmed-meshheading:9649951-Cross-Over Studies
,
pubmed-meshheading:9649951-Diabetes Mellitus, Type 2
,
pubmed-meshheading:9649951-Double-Blind Method
,
pubmed-meshheading:9649951-Drug Administration Schedule
,
pubmed-meshheading:9649951-Drug Therapy, Combination
,
pubmed-meshheading:9649951-Female
,
pubmed-meshheading:9649951-Glipizide
,
pubmed-meshheading:9649951-Humans
,
pubmed-meshheading:9649951-Hypoglycemic Agents
,
pubmed-meshheading:9649951-Insulin
,
pubmed-meshheading:9649951-Male
,
pubmed-meshheading:9649951-Middle Aged
pubmed:year
1998
pubmed:articleTitle
Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus.
pubmed:affiliation
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't